Relationship between stent malapposition and incomplete neointimal coverage after drug-eluting stent implantation

Journal of Interventional Cardiology

Volumn 25, Issue 3, 2012, Pages 270-277

  Kim, Byeong Keuk ^a   Hong, Myeong Ki ^a   Shin, Dong Ho ^a   Kim, Jung Sun ^a   Ko, Young Guk ^a   Choi, Donghoon ^a   Jang, Yangsoo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYPHER; ENDEAVOR; ENDEAVOR RESOLUTE; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG; ZOTAROLIMUS;

ADULT; ARTICLE; CALCULATION; CORONARY STENT; CORRELATION ANALYSIS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STENT MALAPPOSITION;

CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICAL ERRORS; NEOINTIMA; STENTS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84862812751     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2011.00706.x     Document Type: Article

References (25)

1. Morice MC, Serruys PW, Sousa JE, et al. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions: A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323. (Pubitemid 37186209)
3. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130. (Pubitemid 40617065)
4. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007;369:667-678. (Pubitemid 46281313)
5. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007;115:2435-2441. (Pubitemid 46717966)
6. Prati F, Regar E, Mintz GS, et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: Physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2010;31:401-415.
7. Takano M, Inami S, Jang IK, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 2007;99:1033-1038. (Pubitemid 46560470)
8. Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426-2434. (Pubitemid 46717965)
9. Hassan AK, Bergheanu SC, Stijnen T, et al. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J 2010;31:1172-1180.
10. Kim JS, Hong MK, Fan C, et al. Intracoronary thrombus formation after drug-eluting stents implantation: Optical coherence tomographic study. Am Heart J 2010;159:278-283.
11. Kim U, Kim JS, Kim JS, et al. The initial extent of malapposition in ST-elevation myocardial infarction treated with drugeluting stent: The usefulness of optical coherence tomography. Yonsei Med J 2010;51:332-338.
12. Barlis P, Dimopoulos K, Tanigawa J, et al. Quantitative analysis of intracoronary optical coherence tomography measurements of stent strut apposition and tissue coverage. Int J Cardiol 2010;141:151-156.
13. Tanigawa J, Barlis P, Di Mario C. Intravascular optical coherence tomography: Optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention 2007;3:128-136.
14. Tanigawa J, Barlis P, Dimopoulos K, et al. The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. Int J Cardiol 2009;134:180-188.
15. Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006;97:1713-1717. (Pubitemid 43817856)
16. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202. (Pubitemid 43929240)
17. Hong MK, Mintz GS, Lee CW, et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 2004;109:881-886. (Pubitemid 38252740)
18. Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation: An intravascular ultrasound analysis with long-term follow-up. Circulation 2006;113:414-419. (Pubitemid 43803203)
19. Degertekin M, Serruys PW, Tanabe K, et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: An intravascular ultrasound analysis. Circulation 2003;108:2747-2750. (Pubitemid 37498975)
20. Tanabe K, Serruys PW, Degertekin M, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: Insights from the randomized TAXUS II trial. Circulation 2005;111:900-905. (Pubitemid 40279892)
21. Hong MK,Mintz GS, LeeCW, et al. Impact of late drug-eluting stentmalapposition on 3-year clinical events. J Am Coll Cardiol 2007;50:1515-1516. (Pubitemid 47494599)
22. Lee CW, Kang SJ, Park DW, et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 2010;55:1936-1942.
23. Siqueira DA, Abizaid AA, Costa JR, et al. Late incomplete apposition after drug-eluting stent implantation: Incidence and potential for adverse clinical outcomes. Eur Heart J 2007;28:1304-1309. (Pubitemid 47355986)
24. Alfonso F, Suárez A, Pérez-Vizcayno MJ, et al. Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol 2007;50:2095-2097. (Pubitemid 350087569)
25. Kim WH, Lee BK, Lee S, et al. Serial changes of minimal stent malapposition not detected by intravascular ultrasound: Follow-up optical coherence tomography study. Clin Res Cardiol 2010;99:639-644.